House committee schedules DTC hearing
Executive Summary
The House Energy and Commerce Subcommittee on Oversight and Investigations has scheduled a May 8 hearing on direct-to-consumer advertising of drugs. The committee has not yet released a witness list, but the hearing agenda likely is to include discussion on Merck and Schering-Plough's failure to release ENHANCE trial data while running DTC ads for Vytorin (1"The Pink Sheet," Jan. 21, 2008, p. 10). The practice of using celebrities and doctors to endorse drugs in advertising, such as the appearance of artificial-heart inventor Robert Jarvik in ads for Lipitor, will likely also come up (2"The Pink Sheet," Jan. 14, 2008, In Brief)
You may also be interested in...
Vytorin Gets Medical Group Support, Congressional Query On ENHANCE
Merck/Schering-Plough's Vytorin has drawn support from major medical groups as it faces a new Congressional inquiry and possible legal action in the wake of unfavorable study results from the much-anticipated ENHANCE trial
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.